The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADICET BIO INC COM 007002108 13,203 17,488 SH SOLE 17,488 0 0
BERKSHIRE HATHAWAY INC DEL CL B NEW 084670702 248,816 467 SH SOLE 467 0 0
BICARA THERAPEUTICS INC COM 055477103 142,562 10,941 SH SOLE 10,941 0 0
CARDIFF ONCOLOGY INC COM 14147L108 41,721 13,287 SH SOLE 13,287 0 0
COMPASS THERAPEUTICS INC COM 20454B104 82,584 43,465 SH SOLE 43,465 0 0
CONTEXT THERAPEUTICS INC COM 21077P108 11,263 18,403 SH SOLE 18,403 0 0
INHIBIKASE THERAPEUTICS INC COM NEW 45719W205 35,901 16,393 SH SOLE 16,393 0 0
KYVERNA THERAPEUTICS INC COM 501976104 44,354 22,981 SH SOLE 22,981 0 0
LEXEO THERAPEUTICS INC COM 52886X107 61,943 17,851 SH SOLE 17,851 0 0
MIND MEDICINE MINDMED INC COM NEW 60255C885 199,327 34,073 SH SOLE 34,073 0 0
REZOLUTE INC COM NEW 76200L309 3,825,004 1,318,967 SH SOLE 1,318,967 0 0
SPDR GOLD TR GOLD SHS 78463V107 374,101 1,298 SH SOLE 1,298 0 0